Egaptivon pegol

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameEgaptivon pegol
Drug Alias NameARC-1779
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionVon willebrand factor inhibitors
TargetsVon willebrand factor
Therapy Area/IndicationsThrombotic MicroangiopathiesPurpura, Thrombotic Thrombocytopenicvon Willebrand Disease, Type 2 +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesRussian Federation +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArchemix Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArchemix Corp
Active IndicationsN/A
Inactive IndicationsThrombotic MicroangiopathiesPurpura, Thrombotic Thrombocytopenicvon Willebrand Disease, Type 2 +[8] 

Other Information

ATC CodeN/A
Related LinksKEGG